BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND SMO, Q99835, 6608, ENSG00000128602, SMOH, Gx
75 results:

  • 1. Daunorubicin induces GLI1‑dependent apoptosis in colorectal cancer cell lines.
    Kim BR; Kim DY; Tran NL; Kim BG; Lee SI; Kang SH; Min BY; Hur W; Oh SC
    Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757343
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
    Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
    Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Non-canonical Hedgehog signaling mediates profibrotic hematopoiesis-stroma crosstalk in myeloproliferative neoplasms.
    Pritchard JE; Pearce JE; Snoeren IAM; Fuchs SNR; Götz K; Peisker F; Wagner S; Benabid A; Lutterbach N; Klöker V; Nagai JS; Hannani MT; Galyga AK; Sistemich E; Banjanin B; Flosdorf N; Bindels E; Olschok K; Biaesch K; Chatain N; Bhagwat N; Dunbar A; Sarkis R; Naveiras O; Berres ML; Koschmieder S; Levine RL; Costa IG; Gleitz HFE; Kramann R; Schneider RK
    Cell Rep; 2024 Jan; 43(1):113608. PubMed ID: 38117649
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Ivosidenib in acute myeloid leukemia.
    Bruzzese A; Labanca C; Martino EA; Mendicino F; Lucia E; Olivito V; Neri A; Imovilli A; Morabito F; Vigna E; Gentile M
    Expert Opin Pharmacother; 2023; 24(18):2093-2100. PubMed ID: 37874005
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Glasdegib for the treatment of acute myeloid leukemia.
    Bruzzese A; Martino EA; Labanca C; Mendicino F; Lucia E; Olivito V; Fimognari F; Neri A; Morabito F; Vigna E; Gentile M
    Expert Opin Pharmacother; 2023; 24(14):1537-1543. PubMed ID: 37392098
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. B13, a well-tolerated inhibitor of hedgehog pathway, exhibited potent anti-tumor effects against colorectal carcinoma in vitro and in vivo.
    Wu H; Zhang L; Chen B; Ou B; Xu J; Tian N; Yang D; Ai Y; Chen Q; Quan D; Zhang T; Lv L; Tian Y; Zhang J; Wu S
    Bioorg Chem; 2023 Jun; 135():106488. PubMed ID: 36989734
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: A dual-center retrospective cohort analysis of primary N0 disease.
    O'Connor DM; Murad F; Danesh MJ; Butler W; Smile TD; Ilori EO; Gastman BR; Vidimos A; Waldman AB; Schmults CD; Koyfman S; Ruiz ES
    J Am Acad Dermatol; 2022 Dec; 87(6):1295-1302. PubMed ID: 36063987
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Construction of a target MSNs drugcarrier loaded with siRNA
    Zhang Y; Cai R; Li H; Duan Y; Zhang Y; Jing W; Lv S; Chu X; Cao Z; Yang L; Ming L
    Drug Deliv Transl Res; 2022 Oct; 12(10):2463-2473. PubMed ID: 35113326
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML.
    Jaramillo S; Krisam J; Le Cornet L; Kratzmann M; Baumann L; Sauer T; Crysandt M; Rank A; Behringer D; Teichmann L; Görner M; Trappe RU; Röllig C; Krause S; Hanoun M; Hopfer O; Held G; Buske S; Fransecky L; Kayser S; Schliemann C; Schaefer-Eckart K; Al-Fareh Y; Schubert J; Geer T; Kaufmann M; Brecht A; Niemann D; Kieser M; Bornhäuser M; Platzbecker U; Serve H; Baldus CD; Müller-Tidow C; Schlenk RF
    Trials; 2021 Nov; 22(1):765. PubMed ID: 34732236
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Preclinical immunogenicity testing using anti-drug antibody analysis of GX-G3, Fc-fused recombinant human granulocyte colony-stimulating factor, in rat and monkey models.
    Kim YJ; Koh EM; Song CH; Byun MS; Choi YR; Jeon EJ; Hwang K; Kim SK; Yang SI; Jung KJ
    Sci Rep; 2021 Jun; 11(1):12004. PubMed ID: 34099775
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hedgehog signalling molecule, smo is a poor prognostic marker in bladder cancer.
    Mohd Ariffin K; Abd Ghani F; Hussin H; Md Said S; Yunus R; Veerakumarasivam A; Abdullah MA
    Malays J Pathol; 2021 Apr; 43(1):49-54. PubMed ID: 33903305
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through smo/Gli-1 pathway in acute myeloid leukemia.
    Jiang X; Jiang L; Cheng J; Chen F; Ni J; Yin C; Wang Q; Wang Z; Fang D; Yi Z; Yu G; Zhong Q; Carter BZ; Meng F
    J Transl Med; 2021 Mar; 19(1):117. PubMed ID: 33743723
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [NCTD Retards AML HL60 Cell Proliferation via Targeting Hedgehog/SOX2 axis].
    Fu MY; Chen WW; Gao N; Li S; DU J; Yu WZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):32-37. PubMed ID: 33554793
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hedgehog Signaling: Implications in Cancers and Viral Infections.
    Iriana S; Asha K; Repak M; Sharma-Walia N
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494284
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Expression and Significance of Shh Signaling Pathway in Bone Marrow CD34
    Qin YT; Yao L; Yin Z; Chen S; Wang H; Fan WX; Jiang M; Hao JP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1637-1642. PubMed ID: 33067966
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Hedgehog Pathway Inhibitors: A New Therapeutic Class for the Treatment of Acute Myeloid leukemia.
    Jamieson C; Martinelli G; Papayannidis C; Cortes JE
    Blood Cancer Discov; 2020 Sep; 1(2):134-145. PubMed ID: 34661144
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. <Editors' Choice> How to improve outcomes of elderly patients with acute myeloid leukemia: era of excitement.
    Naoe T
    Nagoya J Med Sci; 2020 May; 82(2):151-160. PubMed ID: 32581396
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. An evaluation of glasdegib for the treatment of acute myelogenous leukemia.
    Thomas X; Heiblig M
    Expert Opin Pharmacother; 2020 Apr; 21(5):523-530. PubMed ID: 32027196
    [No Abstract]    [Full Text] [Related]  

  • 19. Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma.
    Chahal KK; Li J; Kufareva I; Parle M; Durden DL; Wechsler-Reya RJ; Chen CC; Abagyan R
    PLoS One; 2019; 14(9):e0214901. PubMed ID: 31539380
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Efficacy of Hedgehog inhibitors in acute myeloid leukemia and establishment of valid biomarkers].
    Minami Y
    Rinsho Ketsueki; 2019; 60(7):843-846. PubMed ID: 31391375
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.